1. Home
  2. RNST vs ARQT Comparison

RNST vs ARQT Comparison

Compare RNST & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$38.88

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$25.00

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
ARQT
Founded
1904
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
RNST
ARQT
Price
$38.88
$25.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$42.25
$32.14
AVG Volume (30 Days)
699.2K
1.2M
Earning Date
04-27-2026
05-25-2026
Dividend Yield
2.44%
N/A
EPS Growth
27.73
88.79
EPS
1.20
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$31.83
$26.91
Revenue Next Year
$4.58
$30.59
P/E Ratio
$31.39
N/A
Revenue Growth
N/A
91.34
52 Week Low
$27.26
$11.86
52 Week High
$42.11
$31.77

Technical Indicators

Market Signals
Indicator
RNST
ARQT
Relative Strength Index (RSI) 48.49 42.02
Support Level $37.45 $24.81
Resistance Level $39.91 $27.26
Average True Range (ATR) 1.29 1.52
MACD -0.35 -0.00
Stochastic Oscillator 42.19 7.59

Price Performance

Historical Comparison
RNST
ARQT

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: